Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Teva
Fuji
Johnson and Johnson
Merck
US Army
Cerilliant
Daiichi Sankyo
Express Scripts
Citi

Generated: February 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021001

« Back to Dashboard

NDA 021001 describes AXERT, which is a drug marketed by Janssen Pharms and is included in one NDA. It is available from three suppliers. Additional details are available on the AXERT profile page.

The generic ingredient in AXERT is almotriptan malate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the almotriptan malate profile page.
Summary for 021001
Tradename:AXERT
Applicant:Janssen Pharms
Ingredient:almotriptan malate
Patents:0
Therapeutic Class:Antimigraine Agents
Pharmacology for NDA: 021001
Suppliers and Packaging for NDA: 021001
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AXERT almotriptan malate TABLET;ORAL 021001 NDA Patriot Pharmaceuticals, LLC 10147-0961 N 10147-0961-1
AXERT almotriptan malate TABLET;ORAL 021001 NDA Patriot Pharmaceuticals, LLC 10147-0962 N 10147-0962-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 6.25MG BASE
Approval Date:May 7, 2001TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 12.5MG BASE
Approval Date:May 7, 2001TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Fuji
Johnson and Johnson
Daiichi Sankyo
AstraZeneca
Farmers Insurance
Deloitte
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot